Month: February 2026

TEL AVIV, Israel, Feb. 04, 2026 (GLOBE NEWSWIRE) — HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and secured data fabric technologies, today announced an open letter by its CEO, Noah Hershcoviz, to its shareholders. Dear Shareholders, HUB operates in environments where trust failure is not an option. The Company’s foundation is built on military-grade cybersecurity and Secured Data Fabric (“SDF”) infrastructure designed to secure, govern, and operationalize sensitive data across regulated, sovereign, and adversarial environments. That foundation continues to strengthen through HUB’s deployments, ongoing institutional adoption, and growing operational scale. We are witnessing sustained demand by the market and expect to see continued growth during 2026 across our revenue...

Strong efficacy signals showing 33% ORR, 16.6-month PFS, and 27-month OS, improving on the SOC by 2-3X in a difficult-to-treat population Company to launch controlled study in second-line KRAS-mutant MSS mCRC with interim data expected by the end of 2026 Pelareorep now has Fast Track Designation for two gastrointestinal cancers, solidifying its potential as an immunotherapeutic platform therapy in gastrointestinal cancers SAN DIEGO, Feb. 04, 2026 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track Designation to pelareorep in combination with bevacizumab (Avastin®) and leucovorin, fluorouracil, irinotecan (“FOLFIRI”) for the treatment of patients...

MIAMI BEACH, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) — Cuentas, Inc. (OTCID: CUEN & CUENW) (“Cuentas”) Cuentas, Inc. (the “Company”) today announced that it had extended the expiration date of its publicly traded warrants (OTCID: CUENW) (the “Warrants”) from February 4, 2026 to June 30, 2026. The Warrants were issued and sold by the Company on February 4, 2021 as part of a firm commitment public offering of its units, consisting of one share of its common stock, par value $0.001 per share (“Common Stock”), and a warrant to purchase an additional share of Common Stock exercisable for five years at an exercise price of $4.30 per share (the “Warrants”). The Company sold an aggregate of 2,790,697 units at a price to the public of $4.30 per unit in the offering. The Common Stock and the Warrants were offered and sold to the public...

PHOENIX, Feb. 04, 2026 (GLOBE NEWSWIRE) — Fold Holdings, Inc. (NASDAQ: FLD) (“Fold” or the “Company”), a bitcoin financial services company making it easy for individuals to earn, save and spend bitcoin through everyday financial tools, today announced the launch of a new Fold app experience that brings rewards, spending, and account activity together into a single, intuitive financial hub, giving customers a clearer, more convenient view of their money. Over the past year, Fold has paid close attention to how customers use money and bitcoin. The updated app experience reflects that feedback by bringing balances, transactions, bitcoin rewards, and spending activity into a single, easy-to-navigate hub. By simplifying how customers earn, track, and use bitcoin in one place, Fold helps them get more value from each action today while...

This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application in late 2026 Injectable and oral oxyntomodulin (dual GLP-1/glucagon analog) for metabolic and fibrotic disorders advancing with initial Phase 1 data from injectable oxyntomodulin (OXM) expected in late 2026; oral OXM to enter clinic thereafter Industry veteran Steve Rubin joins Entera’s board MIAMI and TEL AVIV, Feb. 04, 2026 (GLOBE NEWSWIRE) — OPKO Health, Inc.  (NASDAQ: OPK), through its wholly owned subsidiary, OPKO Biologics (OPKO), and Entera Bio Ltd. (NASDAQ: ENTX) (Entera or the Company), a leader in the development of oral peptide and protein replacement therapies, today announced...

Zeta Network Group (NASDAQ : ZNB) Evaluates Real-World Asset Tokenisation for Institutional Treasury StrategyNew York, Feb. 04, 2026 (GLOBE NEWSWIRE) — 4 February, 2026:  Zeta Network Group (Nasdaq: ZNB) today outlined its strategic focus on real-world asset (RWA) tokenisation as a potential extension of its institutional digital-asset treasury approach, reflecting its assessment of emerging developments in balance-sheet and capital-management practices. As digital assets gain wider acceptance among public companies, Zeta observes that treasury strategies are evolving beyond simple asset holding toward greater diversification, capital efficiency, and governance-aligned deployment. Real-world asset tokenisation may offer a way to represent familiar financial instruments on-chain in formats aligned with institutional risk, compliance,...

Annual Report for 2025for ROCKWOOL A/SRelease no. 08 – 2026to Nasdaq Copenhagen 4 February 2026 Robust 2025 performance in a volatile and challenged market HighlightsOn 13 January 2026, ROCKWOOL effectively lost control of the Russian business. Consequently, a loss of 392 MEUR from value adjustment related to the Russian business was recognised in 2025. Revenue in 2025 reached 3,877 MEUR, an increase of 1.1 percent in local currencies. 2024 acquisitions accounted for 1.2 percent. In Q4 2025, revenue reached 967 MEUR, an increase of 0.8 percent in local currencies. EBITDA in 2025 was 864 MEUR, with a 22.3 percent EBITDA margin, down 2.1 percentage points to 2024. EBITDA in Q4 2025 was 199 MEUR, with a 20.5 percent EBITDA margin, down 3.2 percentage points. Earnings declined due to the production-related incident in Flums, Switzerland,...